Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nina Stuccio"'
Autor:
Upal Basu Roy, Wendy Selig, Andrea Ferris, Yutao Gong, Meredith K. Chuk, Gideon M. Blumenthal, Nina Stuccio, P. Bonomi, Anne C. Deitz, Alexander Spira, C. J. Delgra, Jinghua He
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1208-1214
Expedited reporting of unexpected serious adverse reactions that occur during clinical trials conducted under an IND is a critical component of the clinical trial process designed to protect patients by identifying potential safety issues with new ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e40970f2563b290817228875b225bc
https://doi.org/10.1007/s43441-020-00145-z
https://doi.org/10.1007/s43441-020-00145-z
Autor:
Nina Stuccio, Nancy Roach, Raymond P. Perez, Annemarie Forrest, Robert Goodwin, Patrick Archdeacon, Jonathan P. Jarow
Publikováno v:
Clinical Trials (London, England)
Clin Trials
Clin Trials
Background/aims: The Food and Drug Administration’s final rule on investigational new drug application safety reporting, effective from 28 March 2011, clarified the reporting requirements for serious and unexpected suspected adverse reactions occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbfa9a009ec865ebf9da126adb13c0b
https://doi.org/10.1177/1740774517700640
https://doi.org/10.1177/1740774517700640
Autor:
Craig A. Solid, Eric M. Chi, Joshua J. Ofman, Norma J. Ofsthun, Mahesh Krishnan, Nina Stuccio-White, Allan J. Collins, Robert M. Brenner, J. Michael Lazarus
Publikováno v:
American Journal of Kidney Diseases. 46:481-488
It is unknown to what degree physicians adjust erythropoietin doses to achieve hemoglobin levels (11.0 to 12.0 g/dL [110 to 120 g/L]) recommended by the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) for patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d4b7e62471986ea743e928e6bec6df
https://doi.org/10.1053/j.ajkd.2005.05.018
https://doi.org/10.1053/j.ajkd.2005.05.018
Publikováno v:
The American Journal of Emergency Medicine. 17:305-307
Patients with chronic renal failure (CRF) are at risk for unique medical emergencies, many of which require hemodialysis for their definitive treatment. This study describes the use of emergency department (ED) hemodialysis in the management of CRF p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82595486a68f44a6fee9adc6bdb7d43
https://doi.org/10.1016/s0735-6757(99)90131-6
https://doi.org/10.1016/s0735-6757(99)90131-6